ranibizumab (ophthalmic) (cont.)
IN THIS ARTICLE
What should I discuss with my health care provider before receiving ranibizumab (Lucentis)?
Do not receive this medication if you are allergic to ranibizumab, or if you have an infection in or around your eye.
FDA pregnancy category C. This medication may be harmful to an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant during treatment.
It is not known whether ranibizumab passes into breast milk or if it could harm a nursing baby. Do not receive this medication without telling your doctor if you are breast-feeding a baby.
How is ranibizumab used (Lucentis)?
Ranibizumab is given as an injection into your eye. Your doctor will use a medicine to numb your eye before giving you the injection. You will receive this injection in your doctor's office or other clinic setting.
Ranibizumab is usually given once a month. After you have received the first 4 injections, your doctor may change your injection schedule to once every 3 months. Follow your doctor's instructions.
For at least 30 minutes after your injection, your eyes will be checked periodically to make sure the injection has not caused any side effects.
To be sure this medication is helping your condition and not causing harmful effects, your eyes will also need to be checked on a regular basis. Do not miss any scheduled visits to your doctor.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Need help identifying pills and medications?
Get breaking medical news.